Table 1 Demographic and clinical characteristics of RCC cancer cases and controls
From: Association of single nucleotide polymorphisms with renal cell carcinoma in Algerian population
Characteristics | Cases | Controls |
|---|---|---|
Age (mean ± SD), yr | 56.27 ± 13.91 | 51.71 ± 13.64 |
Gender (%) | ||
Male | 51 (58.6) | 66 (58) |
Female | 36 (41.4) | 48(42) |
Tumor size (%) | ||
> 7 | 47(54.0) | |
≤ 7 | 35 (40.2) | |
Unknown | 5 (5.7) | |
Tumor stage (%) | ||
pT1 | 28 (32.2) | |
pT2 | 21 (24.1) | |
pT3 | 30 (34.5) | |
PT4 | 5 (5.7) | |
Unknown | 3 (3.4) | |
Tumor grade (%) | ||
I | 1 (1.1) | |
II | 39 (44.8) | |
III | 28 (32.2) | |
IV | 13 (14.9) | |
Unknown | 6 (6.9) | |
Location (%) | ||
Left | 47 (54) | |
Right | 40 (46) | |
Histopathology (%) | ||
Clear-cell carcinoma | 54 (62.1) | |
Chromophobe cell carcinoma | 14 (16.1) | |
Papillary renal cell carcinoma | 12 (13.7) | |
Bellini-duct carcinoma | 2 (2.3) | |
Renal mucinous tubular carcinoma | 2 (2.3) | |
Primary renal lymphoma (PRL) | 2 (2.3) | |
Renal neuroendocrine tumor (NET) | 1 (1.15) | |